ID TGM2_PAGMA Reviewed; 695 AA. AC P52181; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1996, sequence version 1. DT 27-MAR-2024, entry version 110. DE RecName: Full=Protein-glutamine gamma-glutamyltransferase 2 {ECO:0000305}; DE EC=2.3.2.13 {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Fish-derived transglutaminase {ECO:0000303|PubMed:11080504}; DE Short=FTG {ECO:0000303|PubMed:11080504}; DE AltName: Full=Isopeptidase TGM2 {ECO:0000305}; DE EC=3.4.-.- {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Protein-glutamine deamidase TGM2 {ECO:0000305}; DE EC=3.5.1.44 {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Protein-glutamine dopaminyltransferase TGM2 {ECO:0000305}; DE EC=2.3.1.- {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Protein-glutamine histaminyltransferase TGM2 {ECO:0000305}; DE EC=2.3.1.- {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Protein-glutamine noradrenalinyltransferase TGM2 {ECO:0000305}; DE EC=2.3.1.- {ECO:0000250|UniProtKB:P08587}; DE AltName: Full=Protein-glutamine serotonyltransferase TGM2 {ECO:0000305}; DE EC=2.3.1.- {ECO:0000250|UniProtKB:P21980}; DE AltName: Full=Tissue transglutaminase {ECO:0000303|PubMed:7556189}; DE AltName: Full=Tissue-type transglutaminase {ECO:0000303|PubMed:7556189}; DE AltName: Full=Transglutaminase-2 {ECO:0000250|UniProtKB:P21980}; DE Short=TGase-2 {ECO:0000250|UniProtKB:P21980}; GN Name=tgm2 {ECO:0000250|UniProtKB:P21980}; OS Pagrus major (Red sea bream) (Chrysophrys major). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Actinopterygii; Neopterygii; Teleostei; Neoteleostei; Acanthomorphata; OC Eupercaria; Spariformes; Sparidae; Pagrus. OX NCBI_TaxID=143350; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE. RC TISSUE=Liver; RX PubMed=7556189; DOI=10.1111/j.1432-1033.1995.tb20826.x; RA Yasueda H., Nakanishi K., Kumazawa Y., Nagase K., Motoki M., Matsui H.; RT "Tissue-type transglutaminase from red sea bream (Pagrus major). Sequence RT analysis of the cDNA and functional expression in Escherichia coli."; RL Eur. J. Biochem. 232:411-419(1995). RN [2] {ECO:0007744|PDB:1G0D} RP X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS), AND ACTIVE SITE. RX PubMed=11080504; DOI=10.1074/jbc.m009862200; RA Noguchi K., Ishikawa K., Yokoyama K., Ohtsuka T., Nio N., Suzuki E.; RT "Crystal structure of red sea bream transglutaminase."; RL J. Biol. Chem. 276:12055-12059(2001). CC -!- FUNCTION: Calcium-dependent acyltransferase that catalyzes the CC formation of covalent bonds between peptide-bound glutamine and various CC primary amines, such as gamma-amino group of peptide-bound lysine, or CC mono- and polyamines, thereby producing cross-linked or aminated CC proteins, respectively. Involved in many biological processes, such as CC bone development, angiogenesis, wound healing, cellular CC differentiation, chromatin modification and apoptosis. Acts as a CC protein-glutamine gamma-glutamyltransferase by mediating the cross- CC linking of proteins: under physiological conditions, the protein cross- CC linking activity is inhibited by GTP; inhibition is relieved by Ca(2+) CC in response to various stresses. When secreted, catalyzes cross-linking CC of proteins of the extracellular matrix, resulting in the formation of CC scaffolds. Plays a key role during apoptosis, both by (1) promoting the CC cross-linking of cytoskeletal proteins resulting in condensation of the CC cytoplasm, and by (2) mediating cross-linking proteins of the CC extracellular matrix, resulting in the irreversible formation of CC scaffolds that stabilize the integrity of the dying cells before their CC clearance by phagocytosis, thereby preventing the leakage of harmful CC intracellular components. In addition to protein cross-linking, can use CC different monoamine substrates to catalyze a vast array of protein CC post-translational modifications: mediates aminylation of serotonin, CC dopamine, noradrenaline or histamine into glutamine residues of target CC proteins to generate protein serotonylation, dopaminylation, CC noradrenalinylation or histaminylation, respectively (By similarity). CC Mediates protein serotonylation of small GTPases during activation and CC aggregation of platelets, leading to constitutive activation of these CC GTPases (By similarity). Plays a key role in chromatin organization by CC mediating serotonylation and dopaminylation of histone H3. Catalyzes CC serotonylation of 'Gln-5' of histone H3 (H3Q5ser) during serotonergic CC neuron differentiation, thereby facilitating transcription. Acts as a CC mediator of neurotransmission-independent role of nuclear dopamine in CC ventral tegmental area (VTA) neurons: catalyzes dopaminylation of 'Gln- CC 5' of histone H3 (H3Q5dop), thereby regulating relapse-related CC transcriptional plasticity in the reward system. Also acts as a protein CC deamidase by mediating the side chain deamidation of specific glutamine CC residues of proteins to glutamate. May also act as an isopeptidase CC cleaving the previously formed cross-links. Also able to participate in CC signaling pathways independently of its acyltransferase activity: acts CC as a signal transducer in alpha-1 adrenergic receptor-mediated CC stimulation of phospholipase C-delta (PLCD) activity and is required CC for coupling alpha-1 adrenergic agonists to the stimulation of CC phosphoinositide lipid metabolism (By similarity). CC {ECO:0000250|UniProtKB:P08587, ECO:0000250|UniProtKB:P21980}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-glutaminyl-[protein] + L-lysyl-[protein] = [protein]-L- CC lysyl-N(6)-5-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:54816, CC Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:14005, CC ChEBI:CHEBI:28938, ChEBI:CHEBI:29969, ChEBI:CHEBI:30011, CC ChEBI:CHEBI:138370; EC=2.3.2.13; CC Evidence={ECO:0000250|UniProtKB:P21980, ECO:0000255|PROSITE- CC ProRule:PRU10024}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54817; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-glutaminyl-[protein] + serotonin = 5-serotonyl-L-glutamyl- CC [protein] + NH4(+); Xref=Rhea:RHEA:66552, Rhea:RHEA-COMP:10207, CC Rhea:RHEA-COMP:17052, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, CC ChEBI:CHEBI:167174, ChEBI:CHEBI:350546; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66553; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- CATALYTIC ACTIVITY: CC Reaction=dopamine + L-glutaminyl-[protein] = 5-dopaminyl-L-glutamyl- CC [protein] + NH4(+); Xref=Rhea:RHEA:66556, Rhea:RHEA-COMP:10207, CC Rhea:RHEA-COMP:17053, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, CC ChEBI:CHEBI:59905, ChEBI:CHEBI:167175; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66557; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- CATALYTIC ACTIVITY: CC Reaction=histamine + L-glutaminyl-[protein] = 5-histaminyl-L-glutamyl- CC [protein] + NH4(+); Xref=Rhea:RHEA:66564, Rhea:RHEA-COMP:10207, CC Rhea:RHEA-COMP:17056, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, CC ChEBI:CHEBI:58432, ChEBI:CHEBI:167179; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66565; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(R)-noradrenaline + L-glutaminyl-[protein] = 5-(R)- CC noradrenalinyl-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:66560, CC Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:17054, ChEBI:CHEBI:28938, CC ChEBI:CHEBI:30011, ChEBI:CHEBI:72587, ChEBI:CHEBI:167178; CC Evidence={ECO:0000250|UniProtKB:P08587}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66561; CC Evidence={ECO:0000250|UniProtKB:P08587}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-glutaminyl-[protein] = L-glutamyl-[protein] + NH4(+); CC Xref=Rhea:RHEA:16441, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:10208, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:28938, ChEBI:CHEBI:29973, CC ChEBI:CHEBI:30011; EC=3.5.1.44; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16442; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; CC Evidence={ECO:0000250|UniProtKB:P21980}; CC -!- ACTIVITY REGULATION: Acyltransferase activity is regulated by the CC binding of GTP and Ca(2+): inactivated by GTP, which stabilizes its CC closed structure, thereby obstructing the accessibility of substrates CC to the active sites. In contrast, Ca(2+) acts as a cofactor by inducing CC conformational change to the active open form. In absence of Ca(2+), CC Mg(2+) may bind Ca(2+)-binding sites, promoting GTP-binding and CC subsequent inhibition of the acyltransferase activity. CC {ECO:0000250|UniProtKB:P21980}. CC -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P21980}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:P21980}. Nucleus {ECO:0000250|UniProtKB:P21980}. CC Chromosome {ECO:0000250|UniProtKB:P21980}. Secreted, extracellular CC space, extracellular matrix {ECO:0000250|UniProtKB:P21980}. Cell CC membrane {ECO:0000250|UniProtKB:Q9WVJ6}. Mitochondrion CC {ECO:0000250|UniProtKB:P21980}. Note=Mainly localizes to the cytosol. CC Present at much lower level in the nucleus and chromatin. Also secreted CC via a non-classical secretion pathway to the extracellular matrix. CC {ECO:0000250|UniProtKB:P21980}. CC -!- SIMILARITY: Belongs to the transglutaminase superfamily. CC Transglutaminase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; S79761; AAB35370.1; -; mRNA. DR PIR; S66662; S66662. DR PDB; 1G0D; X-ray; 2.50 A; A=1-695. DR PDBsum; 1G0D; -. DR AlphaFoldDB; P52181; -. DR SMR; P52181; -. DR EvolutionaryTrace; P52181; -. DR GO; GO:0000785; C:chromatin; ISS:UniProtKB. DR GO; GO:0005829; C:cytosol; ISS:UniProtKB. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB. DR GO; GO:0005525; F:GTP binding; ISS:UniProtKB. DR GO; GO:0120297; F:histone dopaminyltransferase activity; ISS:UniProtKB. DR GO; GO:0120295; F:histone serotonyltransferase activity; ISS:UniProtKB. DR GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW. DR GO; GO:0120299; F:peptide histaminyltransferase activity; ISS:UniProtKB. DR GO; GO:0120298; F:peptide noradrenalinyltransferase activity; IEA:RHEA. DR GO; GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IEA:UniProtKB-EC. DR GO; GO:0050568; F:protein-glutamine glutaminase activity; ISS:UniProtKB. DR GO; GO:0060348; P:bone development; ISS:UniProtKB. DR GO; GO:1903351; P:cellular response to dopamine; ISS:UniProtKB. DR GO; GO:1904015; P:cellular response to serotonin; ISS:UniProtKB. DR GO; GO:0018149; P:peptide cross-linking; ISS:UniProtKB. DR GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB. DR GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB. DR GO; GO:0051057; P:positive regulation of small GTPase mediated signal transduction; ISS:UniProtKB. DR GO; GO:0018277; P:protein deamination; ISS:UniProtKB. DR GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:2000425; P:regulation of apoptotic cell clearance; ISS:UniProtKB. DR GO; GO:0042981; P:regulation of apoptotic process; ISS:UniProtKB. DR Gene3D; 2.60.40.10; Immunoglobulins; 3. DR Gene3D; 3.90.260.10; Transglutaminase-like; 1. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR014756; Ig_E-set. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR002931; Transglutaminase-like. DR InterPro; IPR036985; Transglutaminase-like_sf. DR InterPro; IPR023608; Transglutaminase_animal. DR InterPro; IPR013808; Transglutaminase_AS. DR InterPro; IPR008958; Transglutaminase_C. DR InterPro; IPR036238; Transglutaminase_C_sf. DR InterPro; IPR001102; Transglutaminase_N. DR PANTHER; PTHR11590:SF73; NOVEL TRANSGLUTAMINASE FAMILY PROTEIN-RELATED; 1. DR PANTHER; PTHR11590; PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE; 1. DR Pfam; PF00927; Transglut_C; 1. DR Pfam; PF01841; Transglut_core; 1. DR Pfam; PF00868; Transglut_N; 1. DR PIRSF; PIRSF000459; TGM_EBP42; 1. DR SMART; SM00460; TGc; 1. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR SUPFAM; SSF81296; E set domains; 1. DR SUPFAM; SSF49309; Transglutaminase, two C-terminal domains; 2. DR PROSITE; PS00547; TRANSGLUTAMINASES; 1. PE 1: Evidence at protein level; KW 3D-structure; Acyltransferase; Calcium; Cell membrane; Chromosome; KW Cytoplasm; Direct protein sequencing; Extracellular matrix; GTP-binding; KW Hydrolase; Membrane; Metal-binding; Mitochondrion; Nucleotide-binding; KW Nucleus; Protease; Secreted; Transferase. FT CHAIN 1..695 FT /note="Protein-glutamine gamma-glutamyltransferase 2" FT /id="PRO_0000213710" FT ACT_SITE 272 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10024, FT ECO:0000305|PubMed:11080504, ECO:0007744|PDB:1G0D" FT ACT_SITE 332 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10024, FT ECO:0000305|PubMed:11080504, ECO:0007744|PDB:1G0D" FT ACT_SITE 355 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10024, FT ECO:0000305|PubMed:11080504, ECO:0007744|PDB:1G0D" FT BINDING 395 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P00488" FT BINDING 397 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P00488" FT BINDING 434 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P21980" FT BINDING 444 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P00488" FT BINDING 449 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P00488" FT BINDING 476..482 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:P21980" FT BINDING 578..581 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:P21980" FT SITE 515 FT /note="Important for catalytic activity" FT /evidence="ECO:0000305|PubMed:11080504, FT ECO:0007744|PDB:1G0D" FT STRAND 8..12 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 15..21 FT /evidence="ECO:0007829|PDB:1G0D" FT TURN 25..27 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 29..31 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 33..35 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 40..48 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 55..63 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 67..76 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 79..81 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 83..88 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 90..98 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 106..115 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 121..124 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 128..133 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 148..154 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 159..166 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 169..176 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 184..193 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 196..200 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 202..208 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 212..223 FT /evidence="ECO:0007829|PDB:1G0D" FT TURN 227..229 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 231..234 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 246..248 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 250..252 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 253..261 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 267..270 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 272..286 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 290..298 FT /evidence="ECO:0007829|PDB:1G0D" FT TURN 301..304 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 306..312 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 327..339 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 350..355 FT /evidence="ECO:0007829|PDB:1G0D" FT TURN 363..365 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 368..372 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 373..378 FT /evidence="ECO:0007829|PDB:1G0D" FT TURN 384..386 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 387..395 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 397..403 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 409..411 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 413..416 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 424..426 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 428..431 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 433..435 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 437..440 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 447..456 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 473..478 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 488..496 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 498..500 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 502..513 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 525..532 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 536..544 FT /evidence="ECO:0007829|PDB:1G0D" FT HELIX 546..549 FT /evidence="ECO:0007829|PDB:1G0D" FT TURN 550..552 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 558..566 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 573..581 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 588..590 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 601..608 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 611..613 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 615..617 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 619..624 FT /evidence="ECO:0007829|PDB:1G0D" FT TURN 625..627 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 628..634 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 636..639 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 644..651 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 657..666 FT /evidence="ECO:0007829|PDB:1G0D" FT STRAND 673..682 FT /evidence="ECO:0007829|PDB:1G0D" SQ SEQUENCE 695 AA; 78216 MW; A9A128345D474CF8 CRC64; MASYKGLIVD VNGRSHENNL AHRTREIDRE RLIVRRGQPF SITLQCSDSL PPKHHLELVL HLGKRDEVVI KVQKEHGARD KWWFNQQGAQ DEILLTLHSP ANAVIGHYRL AVLVMSPDGH IVERADKISF HMLFNPWCRD DMVYLPDESK LQEYVMNEDG VIYMGTWDYI RSIPWNYGQF EDYVMDICFE VLDNSPAALK NSEMDIEHRS DPVYVGRTIT AMVNSNGDRG VLTGRWEEPY TDGVAPYRWT GSVPILQQWS KAGVRPVKYG QCWVFAAVAC TVLRCLGIPT RPITNFASAH DVDGNLSVDF LLNERLESLD SRQRSDSSWN FHCWVESWMS REDLPEGNDG WQVLDPTPQE LSDGEFCCGP CPVAAIKEGN LGVKYDAPFV FAEVNADTIY WIVQKDGQRR KITEDHASVG KNISTKSVYG NHREDVTLHY KYPEGSQKER EVYKKAGRRV TEPSNEIAEQ GRLQLSIKHA QPVFGTDFDV IVEVKNEGGR DAHAQLTMLA MAVTYNSLRR GECQRKTISV TVPAHKAHKE VMRLHYDDYV RCVSEHHLIR VKALLDAPGE NGPIMTVANI PLSTPELLVQ VPGKAVVWEP LTAYVSFTNP LPVPLKGGVF TLEGAGLLSA TQIHVNGAVA PSGKVSVKLS FSPMRTGVRK LLVDFDSDRL KDVKGVTTVV VHKKYRSLIT GLHTD //